Balyasny Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.8M | Buy |
1,518,170
+1,404,441
| +1,235% | +$12.8M | 0.02% | 604 |
|
2025
Q1 | $904K | Buy |
+113,729
| New | +$904K | ﹤0.01% | 1390 |
|
2022
Q4 | – | Sell |
-33,794
| Closed | -$1.32M | – | 2690 |
|
2022
Q3 | $1.32M | Sell |
33,794
-301,872
| -90% | -$11.8M | ﹤0.01% | 1296 |
|
2022
Q2 | $10.8M | Buy |
335,666
+316,390
| +1,641% | +$10.2M | 0.04% | 512 |
|
2022
Q1 | $638K | Buy |
+19,276
| New | +$638K | ﹤0.01% | 1425 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 2266 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2033 |
|
2020
Q4 | – | Sell |
-142,289
| Closed | -$8.7M | – | 1434 |
|
2020
Q3 | $8.7M | Buy |
+142,289
| New | +$8.7M | 0.06% | 366 |
|
2020
Q2 | – | Sell |
-19,038
| Closed | -$547K | – | 1275 |
|
2020
Q1 | $547K | Sell |
19,038
-133,467
| -88% | -$3.83M | 0.01% | 764 |
|
2019
Q4 | $11M | Buy |
+152,505
| New | +$11M | 0.07% | 365 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1487 |
|
2018
Q4 | – | Sell |
-75,593
| Closed | -$10.7M | – | 1534 |
|
2018
Q3 | $10.7M | Buy |
75,593
+61,362
| +431% | +$8.67M | 0.05% | 394 |
|
2018
Q2 | $2.23M | Sell |
14,231
-223,900
| -94% | -$35.1M | 0.01% | 743 |
|
2018
Q1 | $38.4M | Sell |
238,131
-23,069
| -9% | -$3.72M | 0.16% | 162 |
|
2017
Q4 | $43M | Sell |
261,200
-98,602
| -27% | -$16.2M | 0.13% | 169 |
|
2017
Q3 | $22.4M | Buy |
359,802
+169,302
| +89% | +$10.5M | 0.09% | 258 |
|
2017
Q2 | $15.2M | Sell |
190,500
-65,443
| -26% | -$5.21M | 0.06% | 346 |
|
2017
Q1 | $18.2M | Sell |
255,943
-121,417
| -32% | -$8.63M | 0.08% | 274 |
|
2016
Q4 | $19.3M | Buy |
377,360
+147,354
| +64% | +$7.52M | 0.1% | 245 |
|
2016
Q3 | $10.6M | Buy |
230,006
+118,097
| +106% | +$5.44M | 0.06% | 370 |
|
2016
Q2 | $3.37M | Buy |
+111,909
| New | +$3.37M | 0.02% | 469 |
|
2016
Q1 | – | Sell |
-26,250
| Closed | -$1.53M | – | 1278 |
|
2015
Q4 | $1.53M | Buy |
+26,250
| New | +$1.53M | 0.01% | 558 |
|